Professor of Molecular Precision Medicine, M.D.
Director of Science for Life Laboratory (www.SciLifeLab.se)
Olli Kallioniemi received his M.D. in 1984, Ph.D. in 1988. He is the founding director of FIMM – the Institute for Molecular Medicine Finland at the University of Helsinki, as part of the Nordic EMBL partnership in Molecular Medicine (with ongoing adjunct affiliation) and is since 2015 director of SciLifeLab, a national infrastructure for life sciences in Sweden.
OIli Kallioniemi’s research group is currently active in individualized systems medicine of cancer, with a focus on improving the diagnostics and therapy of leukemia, prostate and ovarian cancer. Olli Kallioniemi has facilitated launch of grand challenge initiatives in personalized medicine in Finland and Sweden, involving close collaborations with hospitals, health care organizations and industry.
Olli Kallioniemi is an author of appr 385 publications in PubMed and 586 in Web Of Science (with 46,138 citations, H-index of 107). He is a member of the editorial board of six journals and invited lecturer in over 200 meetings during the past 5 years. He has supervised 27 doctoral theses.
Olli Kallioniemi has been a director and a member of Centers of Excellence (Academy of Finland and Marie Curie Center grant) four times, a co-PI in 11 EU framework grants and in one IMI grant, and participated in four ESFRI/ERIC infrastructure networks. Kallioniemi has also served in the board of the Nordic EMBL Molecular Medicine Partnership (https://www.nordicemblpartnership.org/) and in the EU Life organization (https://www.eulife.eu/).
Olli Kallioniemi is an inventor and co-inventor of 21 issued patents, with a focus on diagnostic technology development, including FISH, CGH, tissue microarrays, cell microarrays and bioinformatic methods.
Olli Kallioniemi has received the Anders Jahre (Young Scientist) Prize, NIH Director’s lecture, Harold G. Pritzker Memorial Lecture (Toronto), AACR team science award and the IFCC-Abbot Award for Molecular Diagnostics and the main annual medical prize in Finland.
Olli Kallioniemi is a member of European Molecular Biology Organization (EMBO), the National Academy of Science and Letters (Finland), European Academy of Cancer Sciences as well as the Nobel Assembly at the Karolinska Institutet.